Publication | Closed Access

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

HypertensionHeart FailureCardiovascular DiseaseMyocardial InfarctionPharmacologyCardiovascular PharmacologyPharmacotherapyMedicineCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionAngiotensin-converting Enzyme Inhibitor